Teladoc Health stock adds SoloVitals and SoloScribe for hospitals on October 7, 2026. Solo spans 15,

The company has integrated artificial intelligence scribing and camera-based vitals monitoring into its virtual care platform for hospitals as it works to recover from significant financial setbacks.

The company has integrated artificial intelligence scribing and camera-based vitals monitoring into its virtual care platform for hospitals as it works to recover from significant financial setbacks.

Teladoc Health (TDOC) has launched two new AI-powered capabilities within its Solo platform for hosp

Teladoc Health, Inc. (NYSE: TDOC ) said Wednesday it is adding two artificial intelligence-powered capabilities to its Solo platform as the virtual care provider looks to help hospitals streamline clinical workflows . The new tools, SoloVitals and SoloScribe, aim to give care teams faster access to patient information while reducing the need for separate technology platforms. Adds Contactless Vital-Sign Monitoring SoloVitals allows clinicians to measure a patient’s heart rate and respiration rate without physical contact. The technology uses the camera on a smartphone or tablet to analyze subtle changes in facial skin color. It relies on remote photoplethysmography, or rPPG, to generate vital-sign measurements during virtual consultations. Teladoc said the clinically validated technology can help clinicians make more informed decisions during remote visits. SoloVitals is currently available to select customers through a private preview. Teladoc expects a broader release in December …

New SoloVitals and SoloScribe capabilities bring contactless vitals and ambient documentation directly into clinical workflowsNEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced two new AI-powered capabilities within Solo, its enterprise smart care platform for hospitals and health systems. SoloVitals and SoloScribe are designed to help health systems bring timely patient insights into the care environment, while reducing te

Las acciones de Teladoc Health registraron 606,9 millones de dólares en ingresos en el segundo trimestre, un 4 por ciento menos año tras año. Analistas

Las acciones de Teladoc Health registraron 606,90 millones de dólares en ingresos en el segundo trimestre, un 4,00 por ciento menos que el año anterior.

Teladoc Health, Inc announced a leadership transition in its legal function. After 11 years with the company, Adam Vandervoort, Chief Legal Officer and Secretary, has informed the company of his decision to resign, effective November 1, 2026. Jonathan Dorfman, Teladoc Health’s current Senior Vice President, Securities and Corporate Law, will succeed Vandervoort and be promoted […]